It has been reported that PD-L1-mediated immune evasion contributes to proliferation and metastasis of tumor cells, and anti-PD-L1 treatment has an encouraging efficacy for patients with different kinds of malignancies [31,32]. The gene discussed is CD274; the disease is neoplasm.